https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-adults-severe-hemophilia
0
0
FDA Approves First Gene Therapy for Adults with Severe Hemophilia A - FDA.gov
6/29/23 at 10:00pm
Organization
FDA.gov
Author
Office of the Commissioner
28 words
0
Comments
FDA approves Roctavian, the first gene therapy for treatment of adults with severe hemophilia A.
You are the first to view
Create an account or login to join the discussion